Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Geert Cauwenbergh currently holds 4,235 shares of RXi Pharmaceuticals Corp (RXII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Geert Cauwenbergh has been a net buyer of RXII stock. They have purchased $258.6K and sold $0 worth of shares.
Geert Cauwenbergh's most recent insider trade was on Feb 17, 2023, when they sold 1,500 shares at $0.00 per share.
Geert Cauwenbergh serves as Executive at RXi Pharmaceuticals Corp (RXII). They have executed 140 insider transactions totaling $258.6K over their tenure at the company.
Geert Cauwenbergh holds the position of Executive at RXi Pharmaceuticals Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Geert Cauwenbergh has shown a buying trading pattern, with $258.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Geert Cauwenbergh was on Sep 28, 2018, when they purchased $86.1K worth of RXII shares. This transaction involved 73,587 shares at $1.17 per share.
Geert Cauwenbergh currently owns 4,235 shares of RXi Pharmaceuticals Corp (RXII), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Geert Cauwenbergh's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Geert Cauwenbergh has 140 Form 4 filings on record as an insider at RXi Pharmaceuticals Corp.
Set alerts for Geert Cauwenbergh and 40,000+ other insiders.